Search Within

Alejandro Luna De Abia

Formats
  1. Meeting Abstract (16)
  2. Journal Article (9)
  3. Review (1)
Groups
  1. Department of Medicine (26)
  2. Hematologic Malignancies, Division of (26)
  3. Center for Hematologic Malignancies (25)
  4. Bone Marrow Transplant (24)
  5. Lymphoma (23)
  6. CTCR Scholars (22)

More Groups

People
  1. Miguel-Angel Perales (24)
  2. Magdalena Corona De Lapuerta (23)
  3. Maria Palomba (23)
  4. Gunjan Shah (22)
  5. Michael Scordo (22)
  6. Roni Shouval (22)

More People

Years
  1. 2025 (6)
  2. 2024 (10)
  3. 2023 (10)
Publications
  1. Blood (15)
  2. Blood Advances (2)
  3. Bone Marrow Transplantation (2)
  4. Transplantation and Cellular Therapy (2)
  5. Blood Cancer Discovery (1)
  6. Blood Cancer Journal (1)

More Publications

Publishers
  1. American Society of Hematology (17)
  2. Nature Publishing Group (3)
  3. Elsevier Inc. (2)
  4. American Association for Cancer Research (1)
  5. Biomed Central Ltd (1)
  6. John Wiley & Sons (1)

More Publishers

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • From widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T- cell therapy: Less is better
    Meeting Abstract

    Melica, G.; Luna De Abia, A.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Landego, I.; Lin, R. J.; Palomba, M. L.; Parascondola, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Evaluation of the impact of tocilizumab use in recipients of CAR T cells for non-Hodgkin lymphoma
    Meeting Abstract

    Cassanello, G.; Luttwak, E.; Devlin, S. M.; Luna De Abia, A.; Corona, M.; Landego, I.; Parascondola, A.; Saldia, A.; Tomas, A. A.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Higher CD4+T cell counts after CAR-T in large B-cell lymphomas are significantly associated with better overall survival
    Meeting Abstract

    Luan, D.; Shouval, R.; Fei, T.; Luttwak, E.; Luna, A.; Corona, M.; Palomba, M. L.; Parascondola, A.; Scordo, M.; Shah, G. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell LyLisocabtagene maraleucel in relapsed/refractory large B-cell lymphoma: Real world analysis from the Cell Therapy Consortiummphoma: Real World Analysis from the Cell Therapy Consortium
    Meeting Abstract

    Riedell, P. A.; Grady, C.; Nastoupil, L. J.; Luna, A.; Ahmed, N.; Maziarz, R. T.; Hu, M.; Brower, J.; Hwang, W. T.; Schuster, S. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-life experience with lenalidomide plus anti-CD20 antibodies for the treatment of patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL)
    Meeting Abstract

    Cassanello, G.; Rivas-Delgado, A.; Luna De Abia, A.; Corona, M.; Luttwak, E.; Okwali, M.; Isgor, I.; Galera, P.; Boardman, A. P.; Caron, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • 18F-FDG PET/CT imaging biomarkers for car-T cell therapy outcomes in large-B-cell lymphoma
    Meeting Abstract

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M.; Luttwak, E.; more...
    Blood (2023)

    Fulltext@MSK | Save